The Blog

2020-

2020-12-20 a
THE COVID-CON I -
"Anyone who has watched cable news or opened a newspaper since March is aware that the corporate media has waged an aggressive campaign against hydroxychloroquine, aided by scientific journal editors and public health officials on both sides of the Atlantic."

The U.S. Media Are Suppressing the Truth about Hydroxychloroquine

Developments overseas have been totally ignored by the American press. And yet, since Election Day, the media have hewed to the “HCQ Bad” narrative.

ince most Americans who want to be vaccinated against COVID-19 will have to wait until spring—and cases are climbing—it is imperative that we focus on therapies to keep people out of the hospital and that we revisit the media-engineered saga of hydroxychloroquine.

Italy’s Council of State last week took a step in the right direction when it reversed the country’s July 22 ban on the off-label use of hydroxychloroquine. They issued this reversal following an appeal from a group of doctors seeking to use the anti-malarial drug for early outpatient treatment of COVID-19.

As cited in the Italian newspaper La Repubblica, Order 7097/2020 holds that the continuing “uncertainty” over the drug’s efficacy demands that they permit the individual doctor and patient to make their own informed decisions about using it.

So far, this development has been totally ignored by the American press. It does not fit the accepted narrative. (As a point of comparison, when a European Union agency recently published a memo linking hydroxychloroquine to “psychiatric disorders and suicidal behavior,” based on data from six patients in Spain, the news merited same-day coverage in Newsweek.)

The current accepted press narrative on hydroxychloroquine is that no evidence exists showing it is effective for treating COVID-19, and that it can, in fact, be harmful. Any person who suggests otherwise is accused of being “anti-science” and a promoter of “conspiracy theories” and “disinformation.”

But the narrative is false. First, there is strong evidence that hydroxychloroquine is helpful in treating COVID-19 when administered early in the disease—notably, from studies by the Mount Sinai Health System in New York and the Henry Ford Health System in Detroit, which both showed that the drug cut the mortality rate for COVID-19 patients nearly in half. Large multi-hospital collaborations in Belgium and the Netherlands and numerous smaller studies have also demonstrated benefits.

Secondly, more than 2 billion people worldwide have taken hydroxychloroquine in its 70-year history, and it is known to be so safe that it can be taken by “pregnant women and nursing mothers,” according to the CDC. By contrast, the largest and most lauded study this year that claiming hydroxychloroquine may cause harm to COVID-19 patients was the scandalous, retracted Lancet paper, which that journal’s own editor called a “monumental fraud.” (read more)

______________________

Permission is hereby granted to any and all to copy and paste any entry on this page and convey it electronically along with its URL,
______________________